{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T10:44:18Z","timestamp":1761648258338,"version":"build-2065373602"},"reference-count":24,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Auris Nasus Larynx"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.anl.2015.02.003","type":"journal-article","created":{"date-parts":[[2015,3,10]],"date-time":"2015-03-10T17:48:47Z","timestamp":1426009727000},"page":"332-336","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Anti-inflammatory effects of a novel non-antibiotic macrolide, EM900, on mucus secretion of airway epithelium"],"prefix":"10.1016","volume":"42","author":[{"given":"Ichiro","family":"Tojima","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shino","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takao","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideaki","family":"Kouzaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Omura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiaki","family":"Sunazuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.anl.2015.02.003_bib0125","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1164\/ajrccm.157.6.9710075","article-title":"Improvement of survival in patients with diffuse panbronchiolitis treated with low-dose erythromycin","volume":"157","author":"Kudoh","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.anl.2015.02.003_bib0130","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s004050050222","article-title":"Effects of macrolides on interleukin-8 secretion from human nasal epithelial cells","volume":"257","author":"Fujita","year":"2000","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.anl.2015.02.003_bib0135","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2500\/105065800782102717","article-title":"Macrolide treatment decreased the size of nasal polyps and IL-8 levels in nasal lavage","volume":"14","author":"Yamada","year":"2000","journal-title":"Am J Rhinol"},{"key":"10.1016\/j.anl.2015.02.003_bib0140","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1093\/jac\/dkr040","article-title":"Effectiveness and safety of macrolides in cystic fibrosis patients: a meta-analysis and systematic review","volume":"66","author":"Cai","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.anl.2015.02.003_bib0145","doi-asserted-by":"crossref","first-page":"469","DOI":"10.2169\/internalmedicine.34.469","article-title":"Effect of 14-membered ring macrolide therapy on chronic respiratory tract infections and polymorphonuclear leukocyte activity","volume":"34","author":"Shirai","year":"1995","journal-title":"Intern Med"},{"key":"10.1016\/j.anl.2015.02.003_bib0150","doi-asserted-by":"crossref","first-page":"4145","DOI":"10.1128\/iai.62.10.4145-4152.1994","article-title":"Role of interleukin-8 [IL-8] and an inhibitory effect of erythromycin on IL-8 release in the airways of patients with chronic airway diseases","volume":"62","author":"Oishi","year":"1994","journal-title":"Infect Immun"},{"key":"10.1016\/j.anl.2015.02.003_bib0155","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1164\/rccm.200212-1437OC","article-title":"In vivo and in vitro effects of macrolide antibiotics on mucus secretion in airway epithelial cells","volume":"168","author":"Shimizu","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.anl.2015.02.003_bib0160","doi-asserted-by":"crossref","first-page":"265714","DOI":"10.1155\/2012\/265714","article-title":"Azithromycin inhibits mucus hypersecretion from airway epithelial cells","volume":"2012","author":"Shimizu","year":"2012","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.anl.2015.02.003_bib0165","doi-asserted-by":"crossref","first-page":"3373","DOI":"10.1016\/j.bmcl.2011.04.004","article-title":"Novel 12-membered non-antibiotic macrolides from erythromycin A; EM900 series as novel leads for anti-inflammatory and\/or immunomodulatory agents","volume":"21","author":"Sugawara","year":"2011","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.anl.2015.02.003_bib0170","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/ja.2012.51","article-title":"Novel 12-membered non-antibiotic macrolides, EM900 series with anti-inflammatory and\/or immunomodulatory activity; synthesis, structure\u2013activity relationships and in vivo study","volume":"65","author":"Sugawara","year":"2012","journal-title":"J Antibiot (Tokyo)"},{"key":"10.1016\/j.anl.2015.02.003_bib0175","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1164\/ajrccm.153.4.8616574","article-title":"Hypertrophic and metaplastic changes of goblet cells in rat nasal epithelium induced by endotoxin","volume":"153","author":"Shimizu","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.anl.2015.02.003_bib0180","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2500\/105065899781389858","article-title":"Monoclonal antibody-detectable carbohydrate epitopes of human nasal secretions are differentially expressed in tissue and diseases","volume":"13","author":"Kishioka","year":"1999","journal-title":"Am J Rhinol"},{"key":"10.1016\/j.anl.2015.02.003_bib0185","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.anl.2011.04.015","article-title":"Efficacy of combined treatment with S-carboxymethylcysteine (carbocisteine) and clarithromycin in chronic rhinosinusitis patients without nasal polyp or with small nasal polyp","volume":"39","author":"Majima","year":"2012","journal-title":"Auris Nasus Larynx"},{"key":"10.1016\/j.anl.2015.02.003_bib0190","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jinf.2007.04.006","article-title":"Regional trends in beta-lactam, macrolide, fluoroquinolone and telithromycin resistance among Streptococcus pneumoniae isolates 2001\u20132004","volume":"55","author":"Felmingham","year":"2007","journal-title":"J Infect"},{"issue":"Suppl. 2","key":"10.1016\/j.anl.2015.02.003_bib0195","doi-asserted-by":"crossref","first-page":"ii3","DOI":"10.1093\/jac\/dki297","article-title":"The Alexander Project: the benefits from a decade of surveillance","volume":"56","author":"Felmingham","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.anl.2015.02.003_bib0200","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/01.mlg.0000154740.48314.d5","article-title":"Increase of macrolide-resistant Streptococcus pneumoniae-expressing mefE or ermB gene in the nasopharynx among children with otitis media","volume":"115","author":"Hotomi","year":"2005","journal-title":"Laryngoscope"},{"key":"10.1016\/j.anl.2015.02.003_bib0205","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/ja.2005.11","article-title":"Macrolides with promotive activity of monocyte to macrophage differentiation","volume":"58","author":"Yoshida","year":"2005","journal-title":"J Antibiot (Tokyo)"},{"key":"10.1016\/j.anl.2015.02.003_bib0210","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1183\/09031936.94.07071275","article-title":"The levels of clarithromycin and its 14-hydroxy metabolite in the lung","volume":"7","author":"Honeybourne","year":"1994","journal-title":"Eur Respir J"},{"issue":"Suppl. A","key":"10.1016\/j.anl.2015.02.003_bib0215","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/jac\/27.suppl_A.61","article-title":"The diffusion of clarithromycin and roxithromycin into nasal mucosa, tonsil and lung in humans","volume":"27","author":"Fraschini","year":"1991","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.anl.2015.02.003_bib0220","first-page":"497","article-title":"Tissue penetration properties of macrolide antibiotics \u2013 comparative tissue distribution of erythromycin-stearate, clarithromycin, roxithromycin and azithromycin in rats","volume":"52","author":"Yoshida","year":"1999","journal-title":"Jpn J Antibiot"},{"key":"10.1016\/j.anl.2015.02.003_bib0225","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S1043-4666(03)00117-0","article-title":"In situ localization of TNFalpha\/beta, TACE and TNF receptors TNF-R1 and TNF-R2 in control and LPS-treated lung tissue","volume":"22","author":"Ermert","year":"2003","journal-title":"Cytokine"},{"key":"10.1016\/j.anl.2015.02.003_bib0230","first-page":"360457","article-title":"Effects of a tumor necrosis factor-\u03b1 antagonist on experimentally induced rhinosinusitis","volume":"2011","author":"Kim","year":"2011","journal-title":"J Biomed Biotechnol"},{"key":"10.1016\/j.anl.2015.02.003_bib0235","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1159\/000334339","article-title":"Effects of a novel nonantibiotic macrolide, EM900, on cytokine and mucin gene expression in a human airway epithelial cell line","volume":"88","author":"Otsu","year":"2011","journal-title":"Pharmacology"},{"key":"10.1016\/j.anl.2015.02.003_bib0240","doi-asserted-by":"crossref","first-page":"6236","DOI":"10.4049\/jimmunol.0900614","article-title":"Regulation of airway MUC5AC expression by IL-1beta and IL-17A; the NF-kappaB paradigm","volume":"183","author":"Fujisawa","year":"2009","journal-title":"J Immunol"}],"container-title":["Auris Nasus Larynx"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0385814615000279?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0385814615000279?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T19:31:02Z","timestamp":1759951862000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0385814615000279"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S0385814615000279"],"URL":"https:\/\/doi.org\/10.1016\/j.anl.2015.02.003","relation":{},"ISSN":["0385-8146"],"issn-type":[{"type":"print","value":"0385-8146"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-inflammatory effects of a novel non-antibiotic macrolide, EM900, on mucus secretion of airway epithelium","name":"articletitle","label":"Article Title"},{"value":"Auris Nasus Larynx","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anl.2015.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}